EE457 Cost-Effectiveness of Dostarlimab Monotherapy for the Second-Line Treatment of Advanced or Recurrent dMMR/MSI-H Endometrial Cancer Patients Previously Treated With Platinum-Based Chemotherapy in Spain
Abstract
Authors
M Iglesias A Manzano D Pérez JM Vinuesa-Hernando D. Pérez-Troncoso N. Vidal-Vilar M. Ferro-Alonso